文献速递贫血与红细胞疾病MDS 与骨髓增殖性肿瘤

三维体外红系造血模型重现骨髓增生异常综合征红系衰竭

A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes.
PubMed 文献 · Leukemia · 2019-08-02

研究建立了一种三维支架培养模型,支持健康供者和MDS-RS患者骨髓单个核细胞或CD34+细胞的终末红系分化。CD34+细胞在三维中可扩增超过四周并生成红系岛和去核红细胞,MDS-RS三维培养可从头生成环形铁粒幼红细胞并维持突变克隆,该模型可用于评估治疗化合物。

要点

  • 三维支架支持CD34+和MNC红系增殖超过四周
  • CD34+三维培养实现最高扩增和成熟,生成红系岛和去核红细胞
  • MDS-RS三维培养从头生成环形铁粒幼红细胞并维持突变克隆

核心结论

  • 三维支架培养模型可重现MDS-RS的终末红系衰竭,并支持突变克隆维持。
  • 该模型可用于评估治疗化合物。

研究设计与样本

  • 研究建立三维支架培养模型,对比二维悬浮培养。
  • 细胞来源为健康供者和MDS-RS患者的骨髓单个核细胞或CD34+富集细胞。

主要发现

  • CD34+细胞在二维悬浮培养中两周内未增殖超过两周,而三维支架支持CD34+和MNC红系增殖超过四周。
  • CD34+细胞在三维培养中实现最高扩增和成熟,包括生成红系岛和去核红细胞。
  • MNC支持多系造血分化和与MDS-RS相关的细胞因子分泌。
  • MDS-RS三维培养支持从头生成环形铁粒幼红细胞并维持突变克隆。

临床怎么用

  • 该三维培养模型可用于体外研究MDS-RS红系衰竭及评估治疗化合物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Established cell culture systems have failed to accurately recapitulate key features of terminal erythroid maturation, hampering our ability to in vitro model and treat diseases with impaired erythropoiesis such as myelodysplastic syndromes with ring sideroblasts (MDS-RS). We developed an efficient and robust three-dimensional (3D) scaffold culture model supporting terminal erythroid differentiation from both mononuclear (MNC) or CD34+-enriched primary bone marrow cells from healthy donors and MDS-RS patients. While CD34+ cells did not proliferate beyond two weeks in 2D suspension cultures, the 3D scaffolds supported CD34+ and MNC erythroid proliferation over four weeks demonstrating the importance of the 3D environment. CD34+ cells cultured in 3D facilitated the highest expansion and maturation of erythroid cells, including generation of erythroblastic islands and enucleated erythrocytes, while MNCs supported multi-lineage hemopoietic differentiation and cytokine secretion relevant for MDS-RS. Importantly, MDS-RS 3D-cultures supported de novo generation of ring sideroblasts and maintenance of the mutated clone. The 3D cultures effectively model a clonal disease characterized by terminal erythroid failure and can be used to assess therapeutic compounds.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Elvarsdóttir EM, Mortera-Blanco T, Dimitriou M, et al. A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes. Leukemia. 2019. PMID: 31375745. doi:10.1038/s41375-019-0532-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。